Marwood Group

Marwood Group

Healthcare-focused strategic advisory and financial services

Overview

Marwood Group helps healthcare investors and operators make informed decisions. It provides healthcare-focused strategic advisory and financial services with offices in New York, Washington, D.C., and London. The firm combines experts from healthcare operations, strategy consulting, investment banking, and government to analyze rules, markets, and deals. Clients include institutional investors and healthcare companies in the United States and Europe. Marwood’s approach centers on understanding healthcare regulations and market dynamics to guide investments, partnerships, and corporate strategy. Unlike firms that focus on a single area, Marwood integrates advisory, finance, and regulatory expertise across North America and Europe to offer local and global insights. The goal is to help clients achieve their business objectives in the healthcare sector by navigating complex regulatory environments, executing transactions, and shaping strategic decisions.

About Marwood Group

Simplify's Rating
Why Marwood Group is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consulting

Financial Services

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Washington DC, District of Columbia

Founded

2000

Get referred to Marwood Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Marwood expanded Payor Enhancement in December 2025 with Cihan Yilmaz joining as Vice President.
  • The firm attended J.P. Morgan Healthcare Conference 2026, strengthening investor and sponsor origination.
  • Open roles in New York and DC show continued demand for healthcare policy talent.

What critics are saying

  • SEC scrutiny remains a reputational stain after Marwood’s 2015 charges and safeguards settlement.
  • Hiring for associates and vice presidents signals steady growth, but client concentration remains opaque.
  • A downturn in healthcare dealmaking would hit Marwood’s advisory fees within one quarter.

What makes Marwood Group unique

  • Marwood combines healthcare policy diligence with commercial strategy across provider, payor, HIT, life sciences.
  • Nayan Ghosh leads Life Sciences and HealthTech, linking FDA strategy with market access.
  • Marwood’s New York, DC, and London footprint supports cross-border healthcare advisory work.

Help us improve and share your feedback! Did you find this helpful?

Company News

Business Wire
May 8th, 2024
Marwood Group Hires Nayan Ghosh To Head Life Sciences & Healthtech Practice

NEW YORK--(BUSINESS WIRE)--Marwood Group, a leading, global healthcare advisory firm known for its deep expertise at the intersection of healthcare policy and commercial strategy, announced today the appointment of Nayan Ghosh as Director, Head of Life Sciences HealthTech. After first joining Marwood in 2017 to help expand the market access and commercial strategy capabilities of the Life Sciences HealthTech practice, Ghosh took a hiatus in 2021 to serve as Head of Commercial Regulatory Strategy at Arcade Therapeutics, targeting some of the first FDA authorizations for non-drug anxiety and depression treatments. “Over the last decade, Marwood’s focus on Life Sciences HealthTech has grown significantly, driven by its synergy with Marwood’s deep expertise, data and analytics capabilities related to healthcare services and delivery. Nayan played a large role in leading this growth, and we are excited to have him return,” said Marwood’s Senior Managing Director Lee Alvarez

Business Wire
May 8th, 2024
Marwood Group Hires Nayan Ghosh To Head Life Sciences Healthtech Practice

NEW YORK--(BUSINESS WIRE)--Marwood Group, a leading, global healthcare advisory firm known for its deep expertise at the intersection of healthcare policy and commercial strategy, announced today the appointment of Nayan Ghosh as Director, Head of Life Sciences HealthTech. After first joining Marwood in 2017 to help expand the market access and commercial strategy capabilities of the Life Sciences HealthTech practice, Ghosh took a hiatus in 2021 to serve as Head of Commercial Regulatory Strategy at Arcade Therapeutics, targeting some of the first FDA authorizations for non-drug anxiety and depression treatments. “Over the last decade, Marwood’s focus on Life Sciences HealthTech has grown significantly, driven by its synergy with Marwood’s deep expertise, data and analytics capabilities related to healthcare services and delivery. Nayan played a large role in leading this growth, and we are excited to have him return,” said Marwood’s Senior Managing Director Lee Alvarez

Recently Posted Jobs

Sign up to get curated job recommendations

Marwood Group is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →